Celanese (CE) Financials

$49.24 +4.47 (+9.98%)

Closing price 03:59 PM Eastern

Extended Trading

$48.95 -0.29 (-0.59%)

As of 05:30 PM Eastern

Annual Income Statements for Celanese

This table shows Celanese's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	304	900	843	1,207	852	1,985	1,890	1,894	1,960	-1,522
Consolidated Net Income / (Loss)	285	906	849	1,213	858	1,992	1,896	1,902	1,964	-1,514
Net Income / (Loss) Continuing Operations	287	908	862	1,218	864	2,004	1,918	1,910	1,973	-1,506
Total Pre-Tax Income	488	1,030	1,075	1,510	988	2,251	2,248	1,421	1,183	-996
Total Operating Income	326	934	858	1,334	834	664	1,946	1,378	1,687	-697
Total Gross Profit	1,318	1,405	1,511	1,972	1,606	1,293	2,682	2,380	2,603	2,356
Total Revenue	5,674	5,389	6,140	7,155	6,297	5,655	8,537	9,673	10,940	10,280
Operating Revenue	5,674	5,389	6,140	7,155	6,297	5,655	8,537	9,673	10,940	10,280
Total Cost of Revenue	4,356	3,984	4,629	5,183	4,691	4,362	5,855	7,293	8,337	7,924
Operating Cost of Revenue	4,356	3,984	4,629	5,183	4,691	4,362	5,855	7,293	8,337	7,924
Total Operating Expenses	992	471	653	638	772	629	736	1,007	916	3,053
Selling, General & Admin Expense	506	378	496	546	483	482	633	824	1,075	1,030
Research & Development Expense	119	78	73	72	67	74	86	112	146	130
Amortization Expense	11	9.00	20	24	24	22	25	62	164	159
Other Operating Expenses / (Income)	-4.00	1.00	-	-	-7.00	5.00	-2.00	1.00	-32	-24
Other Special Charges / (Income)	360	5.00	64	-4.00	205	46	-6.00	8.00	-437	1,758
Total Other Income / (Expense), net	162	96	217	176	154	1,587	302	43	-504	-299
Interest Expense	119	126	122	126	119	109	100	405	727	676
Interest & Investment Income	289	265	293	356	301	1,674	301	422	267	357
Other Income / (Expense), net	-8.00	-43	46	-54	-28	22	101	26	-44	20
Income Tax Expense	201	122	213	292	124	247	330	-489	-790	510
Net Income / (Loss) Discontinued Operations	-2.00	-2.00	-13	-5.00	-6.00	-12	-22	-8.00	-9.00	-8.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-19	6.00	6.00	6.00	6.00	7.00	6.00	8.00	4.00	8.00
Basic Earnings per Share	$2.02	$6.21	$6.11	$8.99	$6.88	$16.85	$16.99	$17.48	$18.01	($13.93)
Weighted Average Basic Shares Outstanding	150.84M	144.94M	137.90M	134.31M	123.93M	117.82M	111.22M	108.38M	108.85M	109.27M
Diluted Earnings per Share	$2.00	$6.18	$6.09	$8.91	$6.84	$16.75	$16.86	$17.34	$17.92	($13.93)
Weighted Average Diluted Shares Outstanding	152.29M	145.67M	138.32M	135.42M	124.65M	118.48M	112.08M	109.24M	109.38M	109.27M
Weighted Average Basic & Diluted Shares Outstanding	150.50M	144.90M	138M	134.30M	119.56M	228.35M	216.06M	216.95M	217.81M	109.33M

This table shows Celanese's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	191	767	91	220	951	698	121	155	116	-1,914
Consolidated Net Income / (Loss)	193	769	93	221	949	701	124	153	120	-1,911
Net Income / (Loss) Continuing Operations	194	770	96	220	950	707	124	154	122	-1,906
Total Pre-Tax Income	321	-70	121	216	714	132	157	183	183	-1,519
Total Operating Income	308	56	251	335	842	259	210	250	248	-1,405
Total Gross Profit	546	384	631	686	673	613	554	641	622	539
Total Revenue	2,301	2,348	2,853	2,795	2,723	2,569	2,611	2,651	2,648	2,370
Operating Revenue	2,301	2,348	2,853	2,795	2,723	2,569	2,611	2,651	2,648	2,370
Total Cost of Revenue	1,755	1,964	2,222	2,109	2,050	1,956	2,057	2,010	2,026	1,831
Operating Cost of Revenue	1,755	1,964	2,222	2,109	2,050	1,956	2,057	2,010	2,026	1,831
Total Operating Expenses	238	333	380	351	-169	354	343	391	374	1,945
Selling, General & Admin Expense	184	269	285	274	244	272	265	255	248	262
Research & Development Expense	25	37	42	40	32	32	34	33	32	31
Amortization Expense	10	30	41	42	41	40	41	38	40	40
Other Operating Expenses / (Income)	2.00	-3.00	-6.00	-15	0.00	-11	-11	9.00	-10	-12
Other Special Charges / (Income)	17	-	18	10	-486	21	14	56	64	1,624
Total Other Income / (Expense), net	13	-126	-130	-119	-128	-127	-53	-67	-65	-114
Interest Expense	154	168	182	182	185	178	169	174	169	164
Interest & Investment Income	137	94	57	61	54	95	102	92	86	77
Other Income / (Expense), net	30	-52	-5.00	2.00	3.00	-44	14	15	18	-27
Income Tax Expense	127	-840	25	-4.00	-236	-575	33	29	61	387
Net Income / (Loss) Discontinued Operations	-1.00	-1.00	-3.00	1.00	-1.00	-6.00	0.00	-1.00	-2.00	-5.00
Net Income / (Loss) Attributable to Noncontrolling Interest	2.00	2.00	2.00	1.00	-2.00	3.00	3.00	-2.00	4.00	3.00
Basic Earnings per Share	$1.76	$7.08	$0.84	$2.02	$8.73	$6.42	$1.11	$1.42	$1.06	($17.52)
Weighted Average Basic Shares Outstanding	108.43M	108.38M	108.63M	108.89M	108.92M	108.85M	109.07M	109.31M	109.34M	109.27M
Diluted Earnings per Share	$1.75	$7.00	$0.83	$2.01	$8.69	$6.39	$1.10	$1.41	$1.06	($17.50)
Weighted Average Diluted Shares Outstanding	109.07M	109.24M	109.19M	109.31M	109.44M	109.38M	109.51M	109.55M	109.54M	109.27M
Weighted Average Basic & Diluted Shares Outstanding	108.43M	216.95M	108.79M	108.85M	108.86M	217.81M	109.22M	109.26M	109.31M	109.33M

This table details how cash moves in and out of Celanese's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	187	-329	-62	-114	24	492	-419	972	297	-843
Net Cash From Operating Activities	862	893	803	1,558	1,454	1,343	1,757	1,819	1,899	966
Net Cash From Continuing Operating Activities	864	891	795	1,568	1,454	1,338	1,742	1,847	1,901	971
Net Income / (Loss) Continuing Operations	285	906	849	1,213	858	1,992	1,896	1,902	1,964	-1,514
Consolidated Net Income / (Loss)	285	906	849	1,213	858	1,992	1,896	1,902	1,964	-1,514
Depreciation Expense	363	295	310	349	356	356	378	478	739	823
Amortization Expense	127	103	46	165	-	-	41	81	66	37
Non-Cash Adjustments To Reconcile Net Income	51	-393	-443	-74	102	-1,385	-126	-70	-426	1,594
Changes in Operating Assets and Liabilities, net	38	-20	33	-85	138	375	-447	-544	-442	31
Net Cash From Discontinued Operating Activities	-2.00	2.00	8.00	-10	0.00	5.00	15	-28	-2.00	-5.00
Net Cash From Investing Activities	-558	-439	-549	-507	-493	592	-1,119	-11,141	-134	-470
Net Cash From Continuing Investing Activities	-558	-439	-549	-507	-493	592	-1,119	-11,141	-134	-470
Purchase of Property, Plant & Equipment	-520	-246	-267	-337	-370	-364	-467	-543	-568	-435
Acquisitions	-6.00	-178	-269	-144	-91	-100	-1,142	-10,589	52	0.00
Divestitures	-	-	-	0.00	0.00	1,575	-	48	480	0.00
Sale and/or Maturity of Investments	-	-	-	0.00	0.00	43	516	0.00	0.00	17
Other Investing Activities, net	-36	-27	-14	-39	-17	-39	-53	-57	-98	-52
Net Cash From Financing Activities	-66	-759	-351	-1,165	-935	-1,471	-1,042	10,290	-1,456	-1,313
Net Cash From Continuing Financing Activities	-66	-759	-351	-1,165	-935	-1,471	-1,042	10,290	-1,456	-1,313
Repayment of Debt	-119	-1,250	-228	-669	-244	-810	-835	-688	-4,315	-1,477
Repurchase of Common Equity	-420	-500	-500	-805	-996	-650	-1,000	-17	0.00	0.00
Payment of Dividends	40	-225	-268	-303	-310	-322	-331	-310	-316	-340
Issuance of Debt	430	1,210	644	612	616	311	1,196	11,305	3,175	503
Other Financing Activities, net	3.00	6.00	1.00	0.00	-1.00	0.00	-72	0.00	0.00	1.00
Effect of Exchange Rate Changes	-51	-24	35	-	-2.00	28	-	4.00	-12	-26

This table details how cash moves in and out of Celanese's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	8,888	-8,163	-341	129	61	448	-322	-298	-372	149
Net Cash From Operating Activities	467	541	-96	762	403	830	101	292	79	494
Net Cash From Continuing Operating Activities	473	544	-97	767	404	827	109	293	76	493
Net Income / (Loss) Continuing Operations	193	769	93	221	949	701	124	153	120	-1,911
Consolidated Net Income / (Loss)	193	769	93	221	949	701	124	153	120	-1,911
Depreciation Expense	105	160	178	181	185	195	227	198	209	189
Non-Cash Adjustments To Reconcile Net Income	-48	30	24	-28	-456	34	-29	30	4.00	1,589
Changes in Operating Assets and Liabilities, net	223	-496	-392	393	-274	-169	-213	-88	-257	589
Net Cash From Discontinued Operating Activities	-6.00	-3.00	1.00	-5.00	-1.00	3.00	-8.00	-1.00	3.00	1.00
Net Cash From Investing Activities	-143	-10,713	-178	-163	375	-168	-151	-91	-100	-128
Net Cash From Continuing Investing Activities	-143	-10,713	-178	-163	375	-168	-151	-91	-100	-128
Purchase of Property, Plant & Equipment	-139	-143	-164	-145	-131	-128	-137	-105	-88	-105
Other Investing Activities, net	-4.00	-27	-23	-18	-17	-40	-14	1.00	-16	-23
Net Cash From Financing Activities	8,600	1,944	-69	-447	-700	-240	-259	-489	-376	-189
Net Cash From Continuing Financing Activities	8,600	1,944	-69	-447	-700	-240	-259	-489	-376	-189
Repayment of Debt	-94	-511	-30	-676	-3,446	-163	-436	-484	-542	-15
Payment of Dividends	-76	-80	-77	-82	-80	-77	-81	-91	-83	-85
Issuance of Debt	8,770	2,535	38	311	2,826	-	257	86	249	-89
Effect of Exchange Rate Changes	-36	65	2.00	-23	-17	26	-13	-10	25	-28

This table presents Celanese's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	8,586	8,357	1,579	9,313	9,476	10,909	11,975	26,272	26,597	22,857
Total Current Assets	2,787	2,472	576	2,874	2,765	3,763	3,807	6,611	6,218	5,145
Cash & Equivalents	967	638	576	439	463	955	536	1,508	1,805	962
Note & Lease Receivable	285	223	-	301	331	450	506	675	541	493
Accounts Receivable	706	801	-	1,017	850	792	1,161	1,379	1,243	1,121
Inventories, net	682	720	-	1,046	1,038	978	1,524	2,808	2,357	2,284
Other Current Assets	49	60	-	40	43	55	80	241	272	285
Plant, Property, & Equipment, net	3,609	3,577	0.00	3,719	3,713	3,939	4,193	5,584	5,584	5,273
Total Noncurrent Assets	2,190	2,308	1,003	2,720	2,998	3,207	3,975	14,077	14,795	12,439
Long-Term Investments	838	852	-	979	975	820	823	1,062	1,220	1,217
Goodwill	705	796	1,003	1,057	1,074	1,166	1,412	7,142	6,977	5,387
Intangible Assets	125	194	-	310	312	319	735	4,105	3,975	3,641
Noncurrent Deferred & Refundable Income Taxes	222	159	-	84	96	259	248	808	1,677	1,251
Other Noncurrent Operating Assets	300	307	-	290	541	643	757	960	946	943
Total Liabilities & Shareholders' Equity	8,586	8,357	-177	9,313	9,476	10,909	11,975	26,272	26,597	22,857
Total Liabilities	5,757	5,336	0.00	5,934	6,578	7,014	7,438	20,167	19,045	17,248
Total Current Liabilities	1,550	1,077	0.00	1,779	1,754	1,973	2,505	4,068	4,072	3,853
Short-Term Debt	513	118	-	561	496	496	791	1,306	1,383	1,501
Accounts Payable	587	625	-	819	780	797	1,160	1,518	1,510	1,228
Current Deferred & Payable Income Tax Liabilities	120	12	-	56	17	0.00	81	43	25	4.00
Other Current Liabilities	330	322	-	343	461	680	473	1,201	1,154	1,120
Total Noncurrent Liabilities	4,207	4,259	0.00	4,155	4,824	5,041	4,933	16,099	14,973	13,395
Long-Term Debt	2,468	2,890	-	2,970	3,409	3,227	3,176	13,373	12,301	11,078
Noncurrent Deferred & Payable Income Tax Liabilities	303	261	-	413	422	749	835	1,564	1,299	1,219
Noncurrent Employee Benefit Liabilities	1,189	893	-	564	589	643	558	411	457	396
Other Noncurrent Operating Liabilities	247	215	-	208	404	422	364	751	916	702
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,829	3,021	3,299	3,379	2,898	3,895	4,537	6,105	7,552	5,609
Total Preferred & Common Equity	2,378	2,588	2,887	2,984	2,507	3,526	4,189	5,637	7,091	5,175
Preferred Stock	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,378	2,588	-177	2,984	2,507	3,526	4,189	5,637	7,091	5,175
Common Stock	136	157	-	233	254	257	333	372	394	409
Retained Earnings	3,621	4,320	-	5,847	6,399	8,091	9,677	11,274	12,929	11,100
Treasury Stock	-1,031	-1,531	-	-2,849	-3,846	-4,494	-5,492	-5,491	-5,488	-5,486
Accumulated Other Comprehensive Income / (Loss)	-348	-358	-177	-247	-300	-328	-329	-518	-744	-848
Noncontrolling Interest	451	433	-	395	391	369	348	468	461	434

This table presents Celanese's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Total Assets	21,337	26,272	26,090	25,649	25,538	26,597	26,033	25,812	25,892	22,857
Total Current Assets	13,192	6,611	6,448	6,252	5,887	6,218	5,945	5,904	5,706	5,145
Cash & Equivalents	9,671	1,508	1,167	1,296	1,357	1,805	1,483	1,185	813	962
Note & Lease Receivable	492	675	707	625	570	541	536	662	688	493
Accounts Receivable	1,120	1,379	1,606	1,338	1,339	1,243	1,289	1,264	1,367	1,121
Inventories, net	1,723	2,808	2,749	2,514	2,337	2,357	2,354	2,464	2,562	2,284
Other Current Assets	186	241	219	268	284	272	283	329	276	285
Plant, Property, & Equipment, net	4,089	5,584	5,588	5,541	5,467	5,584	5,471	5,382	5,431	5,273
Total Noncurrent Assets	4,056	14,077	14,054	13,856	14,184	14,795	14,617	14,526	14,755	12,439
Long-Term Investments	954	1,062	1,049	1,028	1,245	1,220	1,238	1,215	1,253	1,217
Goodwill	1,294	7,142	7,139	7,063	6,991	6,977	6,926	6,899	6,997	5,387
Intangible Assets	645	4,105	4,086	4,007	3,944	3,975	3,902	3,844	3,858	3,641
Noncurrent Deferred & Refundable Income Taxes	222	808	813	832	1,074	1,677	1,618	1,608	1,672	1,251
Other Noncurrent Operating Assets	941	960	967	926	930	946	933	960	975	943
Total Liabilities & Shareholders' Equity	21,337	26,272	26,090	25,649	25,538	26,597	26,033	25,812	25,892	22,857
Total Liabilities	16,043	20,167	19,960	19,561	18,589	19,045	18,502	18,203	18,174	17,248
Total Current Liabilities	2,788	4,068	3,851	3,922	3,616	4,072	4,925	4,626	4,159	3,853
Short-Term Debt	977	1,306	1,386	1,507	1,408	1,383	2,439	1,977	1,607	1,501
Accounts Payable	1,128	1,518	1,445	1,243	1,263	1,510	1,447	1,538	1,446	1,228
Current Deferred & Payable Income Tax Liabilities	128	43	6.00	7.00	18	25	28	5.00	23	4.00
Other Current Liabilities	555	1,201	1,014	1,146	927	1,154	1,011	1,106	1,083	1,120
Total Noncurrent Liabilities	13,255	16,099	16,109	15,639	14,973	14,973	13,577	13,577	14,015	13,395
Long-Term Debt	11,360	13,373	13,396	12,889	12,291	12,301	11,018	11,058	11,324	11,078
Noncurrent Deferred & Payable Income Tax Liabilities	954	1,564	1,518	1,505	1,499	1,299	1,314	1,331	1,314	1,219
Noncurrent Employee Benefit Liabilities	489	411	411	406	396	457	444	435	440	396
Other Noncurrent Operating Liabilities	452	751	784	839	787	916	801	753	937	702
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,294	6,105	6,130	6,088	6,949	7,552	7,531	7,609	7,718	5,609
Total Preferred & Common Equity	4,950	5,637	5,661	5,624	6,491	7,091	7,071	7,166	7,274	5,175
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,950	5,637	5,661	5,624	6,491	7,091	7,071	7,166	7,274	5,175
Common Stock	356	372	365	383	386	394	383	394	397	409
Retained Earnings	10,584	11,274	11,289	11,433	12,308	12,929	12,973	13,051	13,091	11,100
Treasury Stock	-5,492	-5,491	-5,491	-5,490	-5,490	-5,488	-5,488	-5,487	-5,487	-5,486
Accumulated Other Comprehensive Income / (Loss)	-498	-518	-502	-702	-713	-744	-797	-792	-727	-848
Noncontrolling Interest	344	468	469	464	458	461	460	443	444	434

This table displays calculated financial ratios and metrics derived from Celanese's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.58%	-5.02%	13.94%	16.53%	-11.99%	-10.20%	50.96%	13.31%	13.10%	-6.03%
EBITDA Growth	-42.37%	59.53%	-2.25%	42.38%	-35.23%	-10.33%	136.66%	-20.40%	24.71%	-92.52%
EBIT Growth	-57.82%	180.19%	1.46%	41.59%	-37.03%	-14.89%	198.40%	-31.41%	17.02%	-141.21%
NOPAT Growth	-62.04%	329.45%	-16.44%	56.40%	-32.22%	-18.95%	180.87%	11.56%	51.90%	-117.34%
Net Income Growth	-54.03%	217.89%	-6.29%	42.87%	-29.27%	132.17%	-4.82%	0.32%	3.26%	-177.09%
EPS Growth	-50.00%	209.00%	-1.46%	46.31%	-23.23%	144.88%	0.66%	2.85%	3.34%	-177.73%
Operating Cash Flow Growth	-10.40%	3.60%	-10.08%	94.02%	-6.68%	-7.63%	30.83%	3.53%	4.40%	-49.13%
Free Cash Flow Firm Growth	14.07%	-12.24%	1,349.35%	-180.64%	125.59%	-29.95%	-128.82%	-5,176.77%	130.56%	-39.14%
Invested Capital Growth	-3.36%	13.43%	-77.76%	444.47%	-2.49%	-0.28%	34.56%	154.92%	-0.02%	-12.09%
Revenue Q/Q Growth	-3.81%	-0.43%	4.81%	1.36%	-3.92%	2.89%	8.71%	0.76%	2.06%	-1.90%
EBITDA Q/Q Growth	-10.12%	61.93%	14.34%	4.67%	-10.06%	23.46%	17.37%	-15.61%	14.61%	-89.83%
EBIT Q/Q Growth	-44.21%	90.79%	13.14%	-7.04%	-13.89%	40.57%	18.19%	-26.42%	14.73%	-169.79%
NOPAT Q/Q Growth	-52.33%	136.74%	4.84%	-1.05%	-12.86%	34.37%	16.77%	23.52%	-8.65%	-129.85%
Net Income Q/Q Growth	-43.11%	104.05%	5.34%	-7.83%	-6.13%	241.68%	-32.86%	14.65%	-3.35%	-237.89%
EPS Q/Q Growth	-41.00%	98.71%	5.91%	-7.38%	-4.87%	242.54%	-30.99%	15.22%	-3.29%	-239.86%
Operating Cash Flow Q/Q Growth	-3.36%	-17.01%	15.04%	24.34%	-2.48%	-3.73%	21.42%	-2.31%	17.95%	-25.81%
Free Cash Flow Firm Q/Q Growth	76.14%	-57.62%	1,094.46%	-739.95%	-22.53%	27.89%	-120.01%	-2,515.46%	135.38%	56.21%
Invested Capital Q/Q Growth	-8.64%	12.28%	-80.31%	-3.40%	-0.89%	-0.54%	21.35%	159.98%	0.91%	-13.85%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.23%	26.07%	24.61%	27.56%	25.50%	22.86%	31.42%	24.60%	23.79%	22.92%
EBITDA Margin	14.24%	23.92%	20.52%	25.07%	18.45%	18.43%	28.89%	20.29%	22.38%	1.78%
Operating Margin	5.75%	17.33%	13.97%	18.64%	13.24%	11.74%	22.79%	14.25%	15.42%	-6.78%
EBIT Margin	5.60%	16.53%	14.72%	17.89%	12.80%	12.13%	23.98%	14.51%	15.02%	-6.59%
Profit (Net Income) Margin	5.02%	16.81%	13.83%	16.95%	13.63%	35.23%	22.21%	19.66%	17.95%	-14.73%
Tax Burden Percent	58.40%	87.96%	78.98%	80.33%	86.84%	88.49%	84.34%	133.85%	166.02%	152.01%
Interest Burden Percent	153.46%	115.60%	118.92%	117.97%	122.58%	328.13%	109.82%	101.21%	72.00%	147.12%
Effective Tax Rate	41.19%	11.84%	19.81%	19.34%	12.55%	10.97%	14.68%	-34.41%	-66.78%	0.00%
Return on Invested Capital (ROIC)	4.74%	19.41%	24.96%	33.29%	13.52%	11.12%	26.66%	14.61%	15.45%	-2.85%
ROIC Less NNEP Spread (ROIC-NNEP)	13.29%	25.68%	-14.89%	-94.71%	19.23%	84.04%	38.38%	15.28%	7.99%	-12.60%
Return on Net Nonoperating Assets (RNNOA)	4.91%	11.56%	1.90%	3.04%	13.81%	47.53%	18.31%	21.14%	13.31%	-20.16%
Return on Equity (ROE)	9.65%	30.97%	26.87%	36.33%	27.34%	58.65%	44.97%	35.75%	28.76%	-23.01%
Cash Return on Invested Capital (CROIC)	8.15%	6.82%	152.18%	-104.64%	16.05%	11.40%	-2.80%	-72.69%	15.47%	10.02%
Operating Return on Assets (OROA)	3.66%	10.52%	18.20%	23.50%	8.58%	6.73%	17.89%	7.34%	6.22%	-2.74%
Return on Assets (ROA)	3.28%	10.69%	17.09%	22.27%	9.13%	19.54%	16.57%	9.95%	7.43%	-6.12%
Return on Common Equity (ROCE)	8.49%	26.29%	10.25%	15.27%	23.91%	52.09%	41.15%	33.00%	26.81%	-21.44%
Return on Equity Simple (ROE_SIMPLE)	11.98%	35.01%	29.41%	40.65%	34.22%	56.49%	45.26%	33.74%	27.70%	-29.26%
Net Operating Profit after Tax (NOPAT)	192	823	688	1,076	729	591	1,660	1,852	2,814	-488
NOPAT Margin	3.38%	15.28%	11.21%	15.04%	11.58%	10.45%	19.45%	19.15%	25.72%	-4.75%
Net Nonoperating Expense Percent (NNEP)	-8.55%	-6.27%	39.85%	128.01%	-5.71%	-72.92%	-11.72%	-0.68%	7.46%	9.75%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.91%	13.25%	-2.68%
Cost of Revenue to Revenue	76.77%	73.93%	75.39%	72.44%	74.50%	77.14%	68.58%	75.40%	76.21%	77.08%
SG&A Expenses to Revenue	8.92%	7.01%	8.08%	7.63%	7.67%	8.52%	7.41%	8.52%	9.83%	10.02%
R&D to Revenue	2.10%	1.45%	1.19%	1.01%	1.06%	1.31%	1.01%	1.16%	1.33%	1.26%
Operating Expenses to Revenue	17.48%	8.74%	10.64%	8.92%	12.26%	11.12%	8.62%	10.41%	8.37%	29.70%
Earnings before Interest and Taxes (EBIT)	318	891	904	1,280	806	686	2,047	1,404	1,643	-677
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	808	1,289	1,260	1,794	1,162	1,042	2,466	1,963	2,448	183
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.45	3.70	0.00	3.55	5.35	3.98	4.11	1.88	2.34	1.46
Price to Tangible Book Value (P/TBV)	5.30	5.98	0.00	6.56	11.95	6.87	8.43	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.45	1.77	2.04	1.48	2.13	2.48	2.02	1.10	1.52	0.74
Price to Earnings (P/E)	26.99	10.63	14.88	8.78	15.73	7.07	9.11	5.60	8.46	0.00
Dividend Yield	2.06%	2.07%	1.88%	2.62%	2.16%	2.07%	1.72%	2.80%	1.84%	4.05%
Earnings Yield	3.71%	9.41%	6.72%	11.38%	6.36%	14.15%	10.98%	17.85%	11.82%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.47	2.55	11.94	2.40	3.05	2.98	2.82	1.27	1.52	1.15
Enterprise Value to Revenue (EV/Rev)	1.73	2.13	1.95	1.83	2.58	2.80	2.36	2.40	2.53	1.79
Enterprise Value to EBITDA (EV/EBITDA)	12.13	8.91	9.50	7.29	13.96	15.18	8.18	11.81	11.32	100.54
Enterprise Value to EBIT (EV/EBIT)	30.82	12.89	13.24	10.22	20.12	23.05	9.85	16.51	16.86	0.00
Enterprise Value to NOPAT (EV/NOPAT)	51.12	13.95	17.40	12.16	22.24	26.75	12.15	12.52	9.85	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.37	12.86	14.91	8.40	11.15	11.77	11.48	12.75	14.59	19.05
Enterprise Value to Free Cash Flow (EV/FCFF)	29.73	39.69	2.85	0.00	18.74	26.09	0.00	0.00	9.84	10.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.05	1.00	0.00	1.05	1.35	0.96	0.87	2.40	1.81	2.24
Long-Term Debt to Equity	0.87	0.96	0.00	0.88	1.18	0.83	0.70	2.19	1.63	1.98
Financial Leverage	0.37	0.45	-0.13	-0.03	0.72	0.57	0.48	1.38	1.67	1.60
Leverage Ratio	2.94	2.90	1.57	1.63	2.99	3.00	2.71	3.59	3.87	3.76
Compound Leverage Factor	4.52	3.35	1.87	1.92	3.67	9.85	2.98	3.64	2.79	5.53
Debt to Total Capital	51.31%	49.89%	0.00%	51.10%	57.40%	48.87%	46.65%	70.63%	64.44%	69.16%
Short-Term Debt to Total Capital	8.83%	1.96%	0.00%	8.12%	7.29%	6.51%	9.30%	6.28%	6.51%	8.25%
Long-Term Debt to Total Capital	42.48%	47.94%	0.00%	42.98%	50.11%	42.36%	37.35%	64.34%	57.93%	60.91%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.76%	7.18%	0.00%	5.72%	5.75%	4.84%	4.09%	2.25%	2.17%	2.39%
Common Equity to Total Capital	40.93%	42.93%	-5.37%	43.18%	36.85%	46.29%	49.26%	27.12%	33.39%	28.45%
Debt to EBITDA	3.69	2.33	0.00	1.97	3.36	3.57	1.61	7.48	5.59	68.74
Net Debt to EBITDA	1.42	1.15	0.00	1.16	2.09	1.36	1.06	6.17	4.35	56.83
Long-Term Debt to EBITDA	3.05	2.24	0.00	1.66	2.93	3.10	1.29	6.81	5.02	60.54
Debt to NOPAT	15.55	3.65	0.00	3.28	5.35	6.30	2.39	7.93	4.86	-25.78
Net Debt to NOPAT	5.98	1.81	0.00	1.93	3.33	2.39	1.57	6.54	3.79	-21.32
Long-Term Debt to NOPAT	12.87	3.51	0.00	2.76	4.67	5.46	1.91	7.22	4.37	-22.71
Altman Z-Score	2.40	3.00	0.00	3.31	3.24	3.16	3.93	1.58	1.92	1.36
Noncontrolling Interest Sharing Ratio	12.04%	15.11%	61.85%	57.97%	12.52%	11.19%	8.50%	7.67%	6.80%	6.80%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.80	2.30	0.00	1.62	1.58	1.91	1.52	1.63	1.53	1.34
Quick Ratio	1.28	1.57	0.00	1.01	0.96	1.38	0.88	0.88	0.88	0.67
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	330	289	4,194	-3,382	865	606	-175	-9,217	2,817	1,714
Operating Cash Flow to CapEx	167.05%	381.62%	301.88%	480.86%	394.04%	391.55%	399.32%	334.99%	334.33%	222.07%
Free Cash Flow to Firm to Interest Expense	2.77	2.30	34.38	-26.84	7.27	5.56	-1.75	-22.76	3.87	2.54
Operating Cash Flow to Interest Expense	7.24	7.09	6.58	12.37	12.22	12.32	17.57	4.49	2.61	1.43
Operating Cash Flow Less CapEx to Interest Expense	2.91	5.23	4.40	9.79	9.12	9.17	13.17	3.15	1.83	0.79
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.65	0.64	1.24	1.31	0.67	0.55	0.75	0.51	0.41	0.42
Accounts Receivable Turnover	7.53	7.15	0.00	0.00	6.75	6.89	8.74	7.62	8.34	8.70
Inventory Turnover	5.95	5.68	0.00	0.00	4.50	4.33	4.68	3.37	3.23	3.41
Fixed Asset Turnover	1.55	1.50	0.00	0.00	1.69	1.48	2.10	1.98	1.96	1.89
Accounts Payable Turnover	6.48	6.57	0.00	0.00	5.87	5.53	5.98	5.45	5.51	5.79
Days Sales Outstanding (DSO)	48.47	51.04	0.00	0.00	54.11	52.99	41.75	47.92	43.74	41.97
Days Inventory Outstanding (DIO)	61.34	64.22	0.00	0.00	81.08	84.35	77.99	108.40	113.06	106.89
Days Payable Outstanding (DPO)	56.31	55.52	0.00	0.00	62.21	65.98	61.00	67.01	66.28	63.06
Cash Conversion Cycle (CCC)	53.50	59.74	0.00	0.00	72.98	71.36	58.74	89.31	90.52	85.80
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,975	4,509	1,003	5,461	5,325	5,310	7,145	18,214	18,211	16,009
Invested Capital Turnover	1.40	1.27	2.23	2.21	1.17	1.06	1.37	0.76	0.60	0.60
Increase / (Decrease) in Invested Capital	-138	534	-3,506	4,458	-136	-15	1,835	11,069	-3.00	-2,202
Enterprise Value (EV)	9,802	11,484	11,971	13,080	16,219	15,813	20,170	23,186	27,702	18,399
Market Capitalization	8,205	9,563	12,547	10,603	13,401	14,029	17,214	10,609	16,582	7,565
Book Value per Share	$16.21	$18.07	($1.31)	$22.31	$20.74	$30.16	$38.48	$51.99	$65.14	$47.34
Tangible Book Value per Share	$10.55	$11.16	($8.70)	$12.09	$9.27	$17.46	$18.76	($51.74)	($35.47)	($35.25)
Total Capital	5,810	6,029	3,299	6,910	6,803	7,618	8,504	20,784	21,236	18,188
Total Debt	2,981	3,008	0.00	3,531	3,905	3,723	3,967	14,679	13,684	12,579
Total Long-Term Debt	2,468	2,890	0.00	2,970	3,409	3,227	3,176	13,373	12,301	11,078
Net Debt	1,146	1,488	-576	2,082	2,427	1,415	2,608	12,109	10,659	10,400
Capital Expenditures (CapEx)	516	234	266	324	369	343	440	543	568	435
Debt-free, Cash-free Net Working Capital (DFCFNWC)	753	845	0.00	1,186	1,004	798	1,557	2,341	1,724	1,831
Debt-free Net Working Capital (DFNWC)	1,750	1,513	576	1,656	1,507	2,286	2,093	3,849	3,529	2,793
Net Working Capital (NWC)	1,237	1,395	576	1,095	1,011	1,790	1,302	2,543	2,146	1,292
Net Nonoperating Expense (NNE)	-93	-83	-161	-137	-129	-1,401	-236	-50	850	1,026
Net Nonoperating Obligations (NNO)	1,146	1,488	-2,296	2,082	2,427	1,415	2,608	12,109	10,659	10,400
Total Depreciation and Amortization (D&A)	490	398	356	514	356	356	419	559	805	860
Debt-free, Cash-free Net Working Capital to Revenue	13.27%	15.68%	0.00%	16.58%	15.94%	14.11%	18.24%	24.20%	15.76%	17.81%
Debt-free Net Working Capital to Revenue	30.84%	28.08%	9.38%	23.14%	23.93%	40.42%	24.52%	39.79%	32.26%	27.17%
Net Working Capital to Revenue	21.80%	25.89%	9.38%	15.30%	16.06%	31.65%	15.25%	26.29%	19.62%	12.57%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.02	$6.21	$6.11	$8.99	$6.88	$16.85	$16.99	$17.48	$18.01	($13.93)
Adjusted Weighted Average Basic Shares Outstanding	150.84M	144.94M	137.90M	134.31M	123.93M	117.82M	111.22M	108.38M	108.85M	109.27M
Adjusted Diluted Earnings per Share	$2.00	$6.18	$6.09	$8.91	$6.84	$16.75	$16.86	$17.34	$17.92	($13.93)
Adjusted Weighted Average Diluted Shares Outstanding	152.29M	145.67M	138.32M	135.42M	124.65M	118.48M	112.08M	109.24M	109.38M	109.27M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	147.08M	140.93M	135.82M	128.10M	119.56M	228.35M	216.06M	216.95M	217.81M	109.33M
Normalized Net Operating Profit after Tax (NOPAT)	403	828	739	1,073	909	632	1,655	970	875	743
Normalized NOPAT Margin	7.11%	15.36%	12.04%	14.99%	14.43%	11.18%	19.39%	10.03%	8.00%	7.22%
Pre Tax Income Margin	8.60%	19.11%	17.51%	21.10%	15.69%	39.81%	26.33%	14.69%	10.81%	-9.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.67	7.07	7.41	10.16	6.77	6.29	20.47	3.47	2.26	-1.00
NOPAT to Interest Expense	1.61	6.53	5.64	8.54	6.13	5.42	16.60	4.57	3.87	-0.72
EBIT Less CapEx to Interest Expense	-1.66	5.21	5.23	7.59	3.67	3.15	16.07	2.13	1.48	-1.65
NOPAT Less CapEx to Interest Expense	-2.73	4.68	3.46	5.97	3.03	2.28	12.20	3.23	3.09	-1.37
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-14.04%	24.83%	31.57%	24.98%	36.13%	16.16%	17.46%	16.30%	16.09%	-22.46%
Augmented Payout Ratio	133.33%	80.02%	90.46%	91.34%	152.21%	48.80%	70.20%	17.19%	16.09%	-22.46%

This table displays calculated financial ratios and metrics derived from Celanese's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.54%	3.21%	12.41%	12.43%	18.34%	9.41%	-8.48%	-5.15%	-2.75%	-7.75%
EBITDA Growth	-33.38%	-73.03%	-36.05%	-15.36%	132.51%	150.00%	6.37%	-10.62%	-53.88%	-403.17%
EBIT Growth	-40.81%	-99.21%	-55.83%	-33.27%	150.00%	5,275.00%	-8.94%	-21.37%	-68.52%	-766.05%
NOPAT Growth	-58.46%	-92.03%	-54.16%	-11.46%	501.85%	3,438.83%	-16.71%	-38.34%	-85.24%	-170.90%
Net Income Growth	-61.93%	46.20%	-81.55%	-49.31%	391.71%	-8.84%	33.33%	-30.77%	-87.36%	-372.61%
EPS Growth	-61.62%	48.62%	-82.00%	-49.50%	396.57%	-8.71%	32.53%	-29.85%	-87.80%	-373.87%
Operating Cash Flow Growth	-25.87%	-7.36%	-130.38%	53.94%	-13.70%	53.42%	205.21%	-61.68%	-80.40%	-40.48%
Free Cash Flow Firm Growth	-823.57%	-721.24%	-670.91%	-896.07%	-964.51%	112.60%	105.40%	99.36%	96.25%	-12.35%
Invested Capital Growth	18.99%	154.92%	149.81%	145.10%	157.58%	-0.02%	-2.29%	1.54%	2.98%	-12.09%
Revenue Q/Q Growth	-7.44%	2.04%	21.51%	-2.03%	-2.58%	-5.66%	1.63%	1.53%	-0.11%	-10.50%
EBITDA Q/Q Growth	-27.61%	-62.98%	158.54%	22.17%	98.84%	-60.19%	10.00%	2.66%	2.59%	-361.68%
EBIT Q/Q Growth	-33.07%	-98.82%	6,050.00%	36.99%	150.74%	-74.56%	4.19%	18.30%	0.38%	-638.35%
NOPAT Q/Q Growth	-51.70%	-78.94%	408.01%	71.34%	228.34%	23.82%	-88.04%	26.84%	-21.41%	-694.86%
Net Income Q/Q Growth	-55.73%	298.45%	-87.91%	137.63%	329.41%	-26.13%	-82.31%	23.39%	-21.57%	-1,692.50%
EPS Q/Q Growth	-56.03%	300.00%	-88.14%	142.17%	332.34%	-26.47%	-82.79%	28.18%	-24.82%	-1,750.94%
Operating Cash Flow Q/Q Growth	-5.66%	15.85%	-117.74%	893.75%	-47.11%	105.96%	-87.83%	189.11%	-72.95%	525.32%
Free Cash Flow Firm Q/Q Growth	9.85%	-1,083.64%	0.15%	6.51%	3.65%	114.01%	-57.21%	-111.03%	-466.41%	427.85%
Invested Capital Q/Q Growth	-4.43%	159.98%	2.65%	-3.89%	0.43%	0.91%	0.31%	-0.13%	1.86%	-13.85%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.73%	16.35%	22.12%	24.54%	24.72%	23.86%	21.22%	24.18%	23.49%	22.74%
EBITDA Margin	19.25%	6.98%	14.86%	18.53%	37.83%	15.96%	17.27%	17.47%	17.94%	-52.45%
Operating Margin	13.39%	2.39%	8.80%	11.99%	30.92%	10.08%	8.04%	9.43%	9.37%	-59.28%
EBIT Margin	14.69%	0.17%	8.62%	12.06%	31.03%	8.37%	8.58%	10.00%	10.05%	-60.42%
Profit (Net Income) Margin	8.39%	32.75%	3.26%	7.91%	34.85%	27.29%	4.75%	5.77%	4.53%	-80.63%
Tax Burden Percent	60.12%	-1,098.57%	76.86%	102.31%	132.91%	531.06%	78.98%	83.61%	65.57%	125.81%
Interest Burden Percent	94.97%	-1,750.00%	49.19%	64.10%	84.50%	61.40%	70.09%	69.06%	68.80%	106.08%
Effective Tax Rate	39.56%	0.00%	20.66%	-1.85%	-33.05%	-435.61%	21.02%	15.85%	33.33%	0.00%
Return on Invested Capital (ROIC)	12.05%	1.27%	5.33%	9.94%	35.21%	32.44%	3.68%	4.63%	3.57%	-24.93%
ROIC Less NNEP Spread (ROIC-NNEP)	12.46%	11.19%	3.92%	8.22%	32.53%	26.41%	3.32%	4.12%	3.16%	-33.74%
Return on Net Nonoperating Assets (RNNOA)	4.34%	15.48%	5.34%	10.16%	34.04%	44.03%	5.66%	6.77%	4.73%	-53.99%
Return on Equity (ROE)	16.38%	16.75%	10.67%	20.10%	69.24%	76.46%	9.34%	11.39%	8.30%	-78.92%
Cash Return on Invested Capital (CROIC)	5.92%	-72.69%	-72.05%	-67.74%	-63.55%	15.47%	16.94%	12.54%	5.99%	10.02%
Operating Return on Assets (OROA)	8.57%	0.09%	4.47%	6.47%	14.19%	3.46%	3.52%	4.10%	4.09%	-25.12%
Return on Assets (ROA)	4.89%	16.57%	1.69%	4.24%	15.94%	11.29%	1.95%	2.37%	1.85%	-33.52%
Return on Common Equity (ROCE)	15.19%	15.47%	9.88%	18.66%	64.71%	71.26%	8.70%	10.64%	7.79%	-73.56%
Return on Equity Simple (ROE_SIMPLE)	33.52%	0.00%	26.34%	22.69%	31.30%	0.00%	28.21%	26.89%	15.09%	0.00%
Net Operating Profit after Tax (NOPAT)	186	39	199	341	1,120	1,387	166	210	165	-984
NOPAT Margin	8.09%	1.67%	6.98%	12.21%	41.14%	54.00%	6.35%	7.94%	6.24%	-41.50%
Net Nonoperating Expense Percent (NNEP)	-0.41%	-9.92%	1.41%	1.72%	2.67%	6.03%	0.36%	0.51%	0.41%	8.81%
Return On Investment Capital (ROIC_SIMPLE)	-	0.19%	-	-	-	6.53%	-	-	-	-5.41%
Cost of Revenue to Revenue	76.27%	83.65%	77.88%	75.46%	75.28%	76.14%	78.78%	75.82%	76.51%	77.26%
SG&A Expenses to Revenue	8.00%	11.46%	9.99%	9.80%	8.96%	10.59%	10.15%	9.62%	9.37%	11.05%
R&D to Revenue	1.09%	1.58%	1.47%	1.43%	1.18%	1.25%	1.30%	1.24%	1.21%	1.31%
Operating Expenses to Revenue	10.34%	14.18%	13.32%	12.56%	-6.21%	13.78%	13.14%	14.75%	14.12%	82.07%
Earnings before Interest and Taxes (EBIT)	338	4.00	246	337	845	215	224	265	266	-1,432
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	443	164	424	518	1,030	410	451	463	475	-1,243
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.89	1.88	2.02	2.18	2.05	2.34	2.62	2.05	2.03	1.46
Price to Tangible Book Value (P/TBV)	3.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.97	1.10	1.14	1.19	1.24	1.52	1.73	1.39	1.41	0.74
Price to Earnings (P/E)	5.66	5.60	7.71	9.67	6.56	8.46	9.31	7.61	13.55	0.00
Dividend Yield	3.15%	2.80%	2.62%	2.46%	2.29%	1.84%	1.65%	2.09%	2.07%	4.05%
Earnings Yield	17.66%	17.85%	12.97%	10.34%	15.24%	11.82%	10.74%	13.13%	7.38%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.63	1.27	1.31	1.38	1.38	1.52	1.63	1.41	1.40	1.15
Enterprise Value to Revenue (EV/Rev)	1.19	2.40	2.45	2.41	2.32	2.53	2.78	2.44	2.49	1.79
Enterprise Value to EBITDA (EV/EBITDA)	4.90	11.81	14.89	16.02	11.64	11.32	12.34	10.93	14.50	100.54
Enterprise Value to EBIT (EV/EBIT)	5.98	16.51	22.39	26.82	17.37	16.86	18.34	16.61	26.89	0.00
Enterprise Value to NOPAT (EV/NOPAT)	7.61	12.52	13.74	12.00	8.08	9.85	11.00	10.11	15.96	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	6.13	12.75	17.39	14.82	15.45	14.59	14.18	15.83	20.03	19.05
Enterprise Value to Free Cash Flow (EV/FCFF)	29.89	0.00	0.00	0.00	0.00	9.84	9.49	11.33	23.77	10.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.33	2.40	2.41	2.36	1.97	1.81	1.79	1.71	1.68	2.24
Long-Term Debt to Equity	2.15	2.19	2.19	2.12	1.77	1.63	1.46	1.45	1.47	1.98
Financial Leverage	0.35	1.38	1.36	1.24	1.05	1.67	1.71	1.64	1.50	1.60
Leverage Ratio	3.44	3.59	3.48	3.39	3.83	3.87	3.82	3.76	3.51	3.76
Compound Leverage Factor	3.27	-62.89	1.71	2.17	3.24	2.38	2.67	2.59	2.41	3.99
Debt to Total Capital	69.97%	70.63%	70.69%	70.28%	66.35%	64.44%	64.12%	63.14%	62.62%	69.16%
Short-Term Debt to Total Capital	5.54%	6.28%	6.63%	7.36%	6.82%	6.51%	11.62%	9.58%	7.78%	8.25%
Long-Term Debt to Total Capital	64.43%	64.34%	64.06%	62.92%	59.53%	57.93%	52.50%	53.57%	54.84%	60.91%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.95%	2.25%	2.24%	2.27%	2.22%	2.17%	2.19%	2.15%	2.15%	2.39%
Common Equity to Total Capital	28.08%	27.12%	27.07%	27.46%	31.44%	33.39%	33.69%	34.71%	35.23%	28.45%
Debt to EBITDA	5.30	7.48	9.00	9.29	6.41	5.59	5.59	5.54	7.19	68.74
Net Debt to EBITDA	0.74	6.17	7.65	7.79	5.20	4.35	4.46	4.52	6.04	56.83
Long-Term Debt to EBITDA	4.88	6.81	8.15	8.32	5.75	5.02	4.57	4.70	6.29	60.54
Debt to NOPAT	8.23	7.93	8.30	6.96	4.45	4.86	4.98	5.12	7.91	-25.78
Net Debt to NOPAT	1.14	6.54	7.06	5.84	3.60	3.79	3.97	4.18	6.65	-21.32
Long-Term Debt to NOPAT	7.58	7.22	7.52	6.23	3.99	4.37	4.08	4.34	6.93	-22.71
Altman Z-Score	2.13	1.40	1.48	1.55	1.74	1.74	1.78	1.69	1.71	1.25
Noncontrolling Interest Sharing Ratio	7.28%	7.67%	7.35%	7.15%	6.55%	6.80%	6.80%	6.62%	6.15%	6.80%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.73	1.63	1.67	1.59	1.63	1.53	1.21	1.28	1.37	1.34
Quick Ratio	4.05	0.88	0.90	0.83	0.90	0.88	0.67	0.67	0.69	0.67
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-932	-11,030	-11,013	-10,296	-9,920	1,390	595	-66	-372	1,219
Operating Cash Flow to CapEx	335.97%	378.32%	-61.94%	525.52%	307.63%	648.44%	73.72%	278.10%	89.77%	470.48%
Free Cash Flow to Firm to Interest Expense	-6.05	-65.65	-60.51	-56.57	-53.62	7.81	3.52	-0.38	-2.20	7.43
Operating Cash Flow to Interest Expense	3.03	3.22	-0.53	4.19	2.18	4.66	0.60	1.68	0.47	3.01
Operating Cash Flow Less CapEx to Interest Expense	2.13	2.37	-1.38	3.39	1.47	3.94	-0.21	1.07	-0.05	2.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.51	0.52	0.54	0.46	0.41	0.41	0.41	0.41	0.42
Accounts Receivable Turnover	8.38	7.62	6.67	7.76	8.72	8.34	7.39	8.11	7.75	8.70
Inventory Turnover	4.78	3.37	3.59	3.81	4.11	3.23	3.20	3.24	3.29	3.41
Fixed Asset Turnover	2.40	1.98	2.04	2.12	2.24	1.96	1.93	1.93	1.92	1.89
Accounts Payable Turnover	6.34	5.45	5.91	6.46	6.98	5.51	5.65	5.81	5.94	5.79
Days Sales Outstanding (DSO)	43.57	47.92	54.74	47.06	41.87	43.74	49.39	44.99	47.13	41.97
Days Inventory Outstanding (DIO)	76.42	108.40	101.58	95.83	88.79	113.06	113.96	112.53	111.08	106.89
Days Payable Outstanding (DPO)	57.54	67.01	61.78	56.52	52.29	66.28	64.59	62.87	61.42	63.06
Cash Conversion Cycle (CCC)	62.45	89.31	94.54	86.37	78.37	90.52	98.76	94.66	96.78	85.80
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,006	18,214	18,696	17,968	18,046	18,211	18,267	18,244	18,583	16,009
Invested Capital Turnover	1.49	0.76	0.76	0.81	0.86	0.60	0.58	0.58	0.57	0.60
Increase / (Decrease) in Invested Capital	1,118	11,069	11,212	10,637	11,040	-3.00	-429	276	537	-2,202
Enterprise Value (EV)	11,407	23,186	24,468	24,813	24,871	27,702	29,725	25,737	26,083	18,399
Market Capitalization	9,351	10,609	11,433	12,277	13,316	16,582	18,529	14,659	14,774	7,565
Book Value per Share	$45.69	$51.99	$52.19	$51.70	$59.63	$65.14	$64.83	$65.61	$66.57	$47.34
Tangible Book Value per Share	$27.79	($51.74)	($51.29)	($50.06)	($40.83)	($35.47)	($34.45)	($32.75)	($32.77)	($35.25)
Total Capital	17,631	20,784	20,912	20,484	20,648	21,236	20,988	20,644	20,649	18,188
Total Debt	12,337	14,679	14,782	14,396	13,699	13,684	13,457	13,035	12,931	12,579
Total Long-Term Debt	11,360	13,373	13,396	12,889	12,291	12,301	11,018	11,058	11,324	11,078
Net Debt	1,712	12,109	12,566	12,072	11,097	10,659	10,736	10,635	10,865	10,400
Capital Expenditures (CapEx)	139	143	155	145	131	128	137	105	88	105
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,710	2,341	2,816	2,541	2,322	1,724	1,976	2,070	2,341	1,831
Debt-free Net Working Capital (DFNWC)	11,381	3,849	3,983	3,837	3,679	3,529	3,459	3,255	3,154	2,793
Net Working Capital (NWC)	10,404	2,543	2,597	2,330	2,271	2,146	1,020	1,278	1,547	1,292
Net Nonoperating Expense (NNE)	-6.86	-730	106	120	171	686	42	57	45	928
Net Nonoperating Obligations (NNO)	1,712	12,109	12,566	11,880	11,097	10,659	10,736	10,635	10,865	10,400
Total Depreciation and Amortization (D&A)	105	160	178	181	185	195	227	198	209	189
Debt-free, Cash-free Net Working Capital to Revenue	17.81%	24.20%	28.19%	24.68%	21.66%	15.76%	18.47%	19.61%	22.34%	17.81%
Debt-free Net Working Capital to Revenue	118.55%	39.79%	39.88%	37.26%	34.32%	32.26%	32.33%	30.84%	30.10%	27.17%
Net Working Capital to Revenue	108.38%	26.29%	26.00%	22.63%	21.19%	19.62%	9.53%	12.11%	14.76%	12.57%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.76	$7.08	$0.84	$2.02	$8.73	$6.42	$1.11	$1.42	$1.06	($17.52)
Adjusted Weighted Average Basic Shares Outstanding	108.43M	108.38M	108.63M	108.89M	108.92M	108.85M	109.07M	109.31M	109.34M	109.27M
Adjusted Diluted Earnings per Share	$1.75	$7.00	$0.83	$2.01	$8.69	$6.39	$1.10	$1.41	$1.06	($17.50)
Adjusted Weighted Average Diluted Shares Outstanding	109.07M	109.24M	109.19M	109.31M	109.44M	109.38M	109.51M	109.55M	109.54M	109.27M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	108.43M	216.95M	108.79M	108.85M	108.86M	217.81M	109.22M	109.26M	109.31M	109.33M
Normalized Net Operating Profit after Tax (NOPAT)	196	39	213	242	249	196	177	258	208	153
Normalized NOPAT Margin	8.54%	1.67%	7.48%	8.64%	9.15%	7.63%	6.78%	9.71%	7.86%	6.47%
Pre Tax Income Margin	13.95%	-2.98%	4.24%	7.73%	26.22%	5.14%	6.01%	6.90%	6.91%	-64.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.19	0.02	1.35	1.85	4.57	1.21	1.33	1.52	1.57	-8.73
NOPAT to Interest Expense	1.21	0.23	1.09	1.87	6.06	7.79	0.98	1.21	0.98	-6.00
EBIT Less CapEx to Interest Expense	1.29	-0.83	0.50	1.05	3.86	0.49	0.51	0.92	1.05	-9.37
NOPAT Less CapEx to Interest Expense	0.31	-0.62	0.24	1.08	5.35	7.07	0.17	0.61	0.46	-6.64
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	18.69%	16.30%	20.79%	24.69%	15.70%	16.09%	16.04%	17.07%	30.24%	-22.46%
Augmented Payout Ratio	31.59%	17.19%	20.79%	24.69%	15.70%	16.09%	16.04%	17.07%	30.24%	-22.46%

Frequently Asked Questions About Celanese's Financials

When does Celanese's financial year end?

According to the most recent income statement we have on file, Celanese's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Celanese's net income changed over the last 9 years?

Over the last 9 years, Celanese's net income changed from $285 million in 2015 to -$1.51 billion in 2024, a change of -631.2%. Check out Celanese's forecast to explore projected trends and price targets.

What is Celanese's operating income?

Celanese's total operating income in 2024 was -$697 million, based on the following breakdown:

Total Gross Profit: $2.36 billion
Total Operating Expenses: $3.05 billion

How has Celanese revenue changed over the last 9 years?

Over the last 9 years, Celanese's total revenue changed from $5.67 billion in 2015 to $10.28 billion in 2024, a change of 81.2%.

How much debt does Celanese have?

Celanese's total liabilities were at $17.25 billion at the end of 2024, a 9.4% decrease from 2023, and a 199.6% increase since 2015.

How much cash does Celanese have?

In the past 9 years, Celanese's cash and equivalents has ranged from $439 million in 2018 to $1.81 billion in 2023, and is currently $962 million as of their latest financial filing in 2024.

How has Celanese's book value per share changed over the last 9 years?

Over the last 9 years, Celanese's book value per share changed from 16.21 in 2015 to 47.34 in 2024, a change of 192.1%.

Related Companies

This page (NYSE:CE) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celanese (CE) Financials

Frequently Asked Questions About Celanese's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celanese (CE) Financials

Annual Income Statements for Celanese

Quarterly Income Statements for Celanese

Annual Cash Flow Statements for Celanese

Quarterly Cash Flow Statements for Celanese

Annual Balance Sheets for Celanese

Quarterly Balance Sheets for Celanese

Annual Metrics and Ratios for Celanese

Quarterly Metrics and Ratios for Celanese

Frequently Asked Questions About Celanese's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools